Post by radiomics.bio

Exploring how radiomics can advance oncology research and clinical decision-making? Meet us at the ASCO Annual Meeting 2026 in Chicago, and we will answer this question.  Our team will be on site, including the CEO, Wim Vos; the Chief Business Officer, Carlos Contreras Meca; the Medical Director, Andrea Corsi; and the Business Developer, Selen Kisadere; at booth #12118, from May 29 to June 1. We look forward to engaging in discussions with researchers, clinicians, and pharma and biotech partners on the role of radiomics in advancing clinical research and innovation in oncology. To arrange a meeting during ASCO 2026, please contact us directly or schedule a meeting here: https://lnkd.in/dyz3wuTj #ASCO2026 #radiomics #oncology #AIinOncology #precisionmedicine #medicalimaging #cancerresearch #clinicaltrial